Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Silfamin for Common Cold
NCT06497439Phase 2Completed
- Sponsor
- Dexa Medica
- Start
- Jul 2024
- Primary completion
- Sep 2024
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 2 trial of Silfamin in common cold, pharyngitis, sponsored by Dexa Medica. Started Jul 2024; status: completed.
02
Drugs
Silfamin
03
Conditions
common coldpharyngitis
Beyond the preview
Go deeper on NCT06497439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06497439.